Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

• Váldodahkkit: Milad Daneshi-Maskooni (Dahkki), Seyed Ali Keshavarz (Dahkki), Mostafa Qorbani (Dahkki), Siavash Mansouri (Dahkki), Seyed Moayed Alavian (Dahkki), Mahtab Badri-Fariman (Dahkki), Seyed Ali Jazayeri-Tehrani (Dahkki), Gity Sotoudeh (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2019-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green...